Molecular Epidemiology of Parkinson's Disease
1 other identifier
observational
2,022
1 country
1
Brief Summary
The aim of this research is to discover genes which modify risk for Parkinson's disease. The study includes 800 patients with Parkinson's disease, and their estimated 1,222 available siblings. Common variations of at least 9 genes will be studied, including genes associated with personality, substance use, and anxiety and depression.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2000
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2000
CompletedFirst Submitted
Initial submission to the registry
July 24, 2002
CompletedFirst Posted
Study publicly available on registry
July 26, 2002
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2005
CompletedSeptember 29, 2014
July 1, 2002
July 24, 2002
September 26, 2014
Conditions
Keywords
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
Study Sites (1)
Department of Neurology, Mayo Clinic
Rochester, Minnesota, 55905, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Demetrius M Maraganore, MD
Department of Neurology, Mayo Clinic Rochester
Study Design
- Study Type
- observational
- Sponsor Type
- NIH
Study Record Dates
First Submitted
July 24, 2002
First Posted
July 26, 2002
Study Start
September 1, 2000
Study Completion
June 1, 2005
Last Updated
September 29, 2014
Record last verified: 2002-07